09:19 AM EDT, 05/22/2024 (MT Newswires) -- Health care stocks were lower premarket Wednesday as the iShares Biotechnology ETF ( IBB ) was 0.5% lower and the Health Care Select Sector SPDR Fund ( XLV ) was down 0.3% recently.

Eupraxia Pharmaceuticals ( EPRX ) was up more than 13% after saying new clinical data from its phase 1b/2a dose-escalation study of EP-104GI to treat eosinophilic esophagitis showed further positive results.

G1 Therapeutics ( GTHX ) and Jupiter Bioventures' Deimos Biosciences said they have entered a global licensing agreement for lerociclib to treat radiation exposure. G1 Therapeutics ( GTHX ) was over 5% higher pre-bell.

LifeStance Health Group ( LFST ) was over 18% lower after saying a secondary underwritten public offering of 20 million of its common shares was priced at $6.25 per share.